These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 5400246)
1. [Analytical reactions of mefenamic and flufenamic acids]. Devaux G; Mesnard P; Brisson AM Ann Pharm Fr; 1969 Mar; 27(3):239-48. PubMed ID: 5400246 [No Abstract] [Full Text] [Related]
2. [Pharmacological properties of a series of derivatives of mefenamic and flufenamic acids]. Linari G; Spanò R Farmaco Sci; 1971 Apr; 26(4):303-11. PubMed ID: 5559990 [No Abstract] [Full Text] [Related]
3. [The new anti-inflammatory acids. Niflumic acid in rheumatology]. Camus JP Presse Med (1893); 1968 May; 76(22):1071-2. PubMed ID: 5300745 [No Abstract] [Full Text] [Related]
4. [On various derivatives of mefenamic and flufenamic acids]. Spanò R; Marri R Boll Chim Farm; 1968 Aug; 107(8):512-5. PubMed ID: 5721222 [No Abstract] [Full Text] [Related]
8. Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition. Glazko AJ Ann Phys Med; 1966; Suppl():23-36. PubMed ID: 4979052 [No Abstract] [Full Text] [Related]
9. Experimental observations on flufenamic, mefanamic and meclofenamic acids. II. Toxicology in animals. Kaump DH Ann Phys Med; 1966; Suppl():16-23. PubMed ID: 4979051 [No Abstract] [Full Text] [Related]
10. Optical studies of drug-protein complexes. 3. Interaction of flufenamic acid and other N-arylanthranilates with serum albumin. Chignell CF Mol Pharmacol; 1969 Sep; 5(5):455-62. PubMed ID: 5823761 [No Abstract] [Full Text] [Related]
11. Discussion on clinical trials of the fenamates. Ann Phys Med; 1966; Suppl():129-34. PubMed ID: 5306340 [No Abstract] [Full Text] [Related]
12. Structure-activity relationships in a series of anti-inflammatory N-arylanthranilic acids. Kaltenbronn JS; Scherrer RA; Short FW; Jones EM; Beatty HR; Saka MM; Winder CV; Wax J; Williamson WR Arzneimittelforschung; 1983; 33(4A):621-7. PubMed ID: 6683967 [TBL] [Abstract][Full Text] [Related]
13. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects. Holmes EL Ann Phys Med; 1966; Suppl():36-49. PubMed ID: 4895006 [No Abstract] [Full Text] [Related]
14. [Synthesis and pharmacological study of anthranilic acid substitutes and of 2-(substituted phenyl)aminoalkylphenones]. Bellani P; Gallico L; Zoni G Boll Chim Farm; 1974 Sep; 113(9):503-8. PubMed ID: 4447688 [No Abstract] [Full Text] [Related]
15. [Antirheumatics in a narrower sense]. Gross D Ther Umsch; 1972 Aug; 29(8):502-4. PubMed ID: 4538298 [No Abstract] [Full Text] [Related]
16. [Contribution to the evaluation of anti-inflammatory agents in vitro]. Mörsdorf K; Cornelissen G Med Pharmacol Exp Int J Exp Med; 1966; 15(4):399-403. PubMed ID: 6012770 [No Abstract] [Full Text] [Related]
17. Flufenamic acid in rheumatoid arthritis. Drug Ther Bull; 1967 Dec; 5(26):103-4. PubMed ID: 6078914 [No Abstract] [Full Text] [Related]
18. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7. Gaganis P; Miners JO; Knights KM Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829 [TBL] [Abstract][Full Text] [Related]